These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 1717296)
41. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain. Foster AC; Wong EH Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170 [TBL] [Abstract][Full Text] [Related]
42. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Lipton SA Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105 [TBL] [Abstract][Full Text] [Related]
43. Modulation by magnesium of N-methyl-D-aspartate receptors in developing human brain. Chahal H; D'Souza SW; Barson AJ; Slater P Arch Dis Child Fetal Neonatal Ed; 1998 Mar; 78(2):F116-20. PubMed ID: 9577281 [TBL] [Abstract][Full Text] [Related]
44. Supporting evidence for negative modulation by protons of an ion channel associated with the N-methyl-D-aspartate receptor complex in rat brain using ligand binding techniques. Yoneda Y; Enomoto R; Ogita K Brain Res; 1994 Feb; 636(2):298-307. PubMed ID: 7516810 [TBL] [Abstract][Full Text] [Related]
45. Reduced NMDA receptor-ion channel function in the vitamin B-6 restricted neonatal rat brain. Guilarte TR Neurosci Lett; 1991 Jan; 121(1-2):207-10. PubMed ID: 1708479 [TBL] [Abstract][Full Text] [Related]
46. Regional variations in [3H]MK801 binding to rat brain N-methyl-D-aspartate receptors. Reynolds IJ; Palmer AM J Neurochem; 1991 May; 56(5):1731-40. PubMed ID: 1826521 [TBL] [Abstract][Full Text] [Related]
47. MS-377, a selective sigma receptor ligand, indirectly blocks the action of PCP in the N-methyl-D-aspartate receptor ion-channel complex in primary cultured rat neuronal cells. Karasawa J; Yamamoto H; Yamamoto T; Sagi N; Horikomi K; Sora I Life Sci; 2002 Feb; 70(14):1631-42. PubMed ID: 11991251 [TBL] [Abstract][Full Text] [Related]
48. Volatile anesthetics and NMDA receptors. Enflurane inhibition of glutamate-stimulated [3H]MK-801 binding and reversal by glycine. Martin DC; Abraham JE; Plagenhoef M; Aronstam RS Neurosci Lett; 1991 Oct; 132(1):73-6. PubMed ID: 1686307 [TBL] [Abstract][Full Text] [Related]
50. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Parsons CG; Gruner R; Rozental J; Millar J; Lodge D Neuropharmacology; 1993 Dec; 32(12):1337-50. PubMed ID: 8152525 [TBL] [Abstract][Full Text] [Related]
51. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. Chen HS; Lipton SA J Physiol; 1997 Feb; 499 ( Pt 1)(Pt 1):27-46. PubMed ID: 9061638 [TBL] [Abstract][Full Text] [Related]
52. Pharmacological characterization of the N-methyl-D-aspartate (NMDA) receptor-channel in rodent and dog brain and rat spinal cord using [3H]MK-801 binding. Sharif NA; Nunes JL; Whiting RL Neurochem Res; 1991 May; 16(5):563-9. PubMed ID: 1836546 [TBL] [Abstract][Full Text] [Related]
53. Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques. Yoneda Y; Ogita K J Pharmacol Exp Ther; 1991 Oct; 259(1):86-96. PubMed ID: 1681092 [TBL] [Abstract][Full Text] [Related]
54. Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta. Giustizieri M; Cucchiaroni ML; Guatteo E; Bernardi G; Mercuri NB; Berretta N J Pharmacol Exp Ther; 2007 Aug; 322(2):721-9. PubMed ID: 17496164 [TBL] [Abstract][Full Text] [Related]
55. The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. Rammes G; Mahal B; Putzke J; Parsons C; Spielmanns P; Pestel E; Spanagel R; Zieglgänsberger W; Schadrack J Neuropharmacology; 2001 May; 40(6):749-60. PubMed ID: 11369029 [TBL] [Abstract][Full Text] [Related]
56. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. Chen HS; Pellegrini JW; Aggarwal SK; Lei SZ; Warach S; Jensen FE; Lipton SA J Neurosci; 1992 Nov; 12(11):4427-36. PubMed ID: 1432103 [TBL] [Abstract][Full Text] [Related]